Pneumonia
Showing 9976 - 10000 of >10,000
Type 2 Diabetes, Overweight, Obesity Trial in Boston (Canagliflozin, Placebo)
Completed
- Type 2 Diabetes
- +2 more
- Canagliflozin
- Placebo
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 2, 2018
Congenital Cardiac Disorders Trial in Cairo (ultrafiltration)
Completed
- Congenital Cardiac Disorders
- ultrafiltration
-
Cairo, EgyptKasr Alainy Hospital , Faculty of Medicine
Jul 20, 2018
Carcinoma, Non Small Cell Lung Trial in United States (PF-00299804)
Completed
- Carcinoma, Non Small Cell Lung
-
Duarte, California
- +18 more
May 20, 2019
Idiopathic Pulmonary Fibrosis Trial (high resolution computed tomography)
Unknown status
- Idiopathic Pulmonary Fibrosis
- high resolution computed tomography
- (no location specified)
May 30, 2017
Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)
Terminated
- Adenocarcinoma of the Prostate
- +4 more
-
Seattle, WashingtonSeattle Cancer Care Alliance/University of Washington
Nov 6, 2018
Essential Hypertension, Type 2 Diabetes Trial in China, Taiwan, Thailand (Azilsartan Medoxomil)
Completed
- Essential Hypertension
- Type 2 Diabetes Mellitus
- Azilsartan Medoxomil
-
Hong Kong, Hong Kong, China
- +11 more
Oct 29, 2018
Adult T-cell Leukemia-Lymphoma Trial in Worldwide (KW-0761, Pralatrexate, gemcitabine plus oxaliplatin)
Completed
- Adult T-cell Leukemia-Lymphoma
- KW-0761
- +3 more
-
Los Angeles, California
- +19 more
Aug 21, 2018
Post-traumatic Inhibition of Innate and Adaptive Immune System
Terminated
- Multiple Trauma
- +4 more
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Mar 29, 2018
Hypertension Trial in Adelaide, Melbourne, Athens (St. Jude Medical renal artery ablation system: RF ablation generator (IBI
Completed
- Hypertension
- St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002)
-
Adelaide, South Australia, Australia
- +3 more
Feb 1, 2019
Cystic Fibrosis Trial in United States (Arikayce™ 560 mg, Placebo for 560 mg, Arikayce™ 70 mg)
Completed
- Cystic Fibrosis
- Arikayce™ 560 mg
- +4 more
-
Birmingham, Alabama
- +18 more
May 14, 2019
Metastatic Colorectal Cancer Trial in Worldwide (Sym004 (12 mg/kg), Sym004 (9/6 mg/kg), Best Supportive Care (BSC))
Completed
- Metastatic Colorectal Cancer
- Sym004 (12 mg/kg)
- +4 more
-
Los Angeles, California
- +53 more
Apr 9, 2019
Psoriasis Trial in Worldwide (80 mg ixekizumab Dosing Regimen, 50 mg etanercept, Placebo)
Completed
- Psoriasis
- 80 mg ixekizumab Dosing Regimen
- +2 more
-
Phoenix, Arizona
- +117 more
Jun 9, 2020
Solid Tumor or Lymphoma Trial in Amsterdam, Glasgow (Lenvatinib)
Completed
- Solid Tumor or Lymphoma
-
Amsterdam, Netherlands
- +1 more
Mar 20, 2020
Pneumonia, Ventilator Associated Trial (Manual turn, kinetic therapy bed)
Completed
- Pneumonia, Ventilator Associated
- Manual turn
- kinetic therapy bed
- (no location specified)
Mar 8, 2016
B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (Samalizumab)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- Multiple Myeloma
-
Tucson, Arizona
- +3 more
Feb 12, 2019
Chronic Renal Failure Requiring Hemodialysis Trial in Puerto Rico, United States (Epoetin Hospira)
Completed
- Chronic Renal Failure Requiring Hemodialysis
- Epoetin Hospira
-
Azusa, California
- +109 more
Jun 22, 2018
Benign Prostatic Hyperplasia Trial in Evansville (Tamsulosin)
Completed
- Benign Prostatic Hyperplasia
-
Evansville, IndianaResearch Institute of Deaconess Clinic
Nov 1, 2018
Low Bone Mass, Low Bone Mineral Density, Males With Osteoporosis Trial (60 mg denosumab, Placebo)
Completed
- Low Bone Mass
- +4 more
- 60 mg denosumab
- Placebo
- (no location specified)
Sep 20, 2018
Solid Tumor Trial in Chicago (capecitabine, celecoxib, pharmacological study)
Terminated
- Unspecified Adult Solid Tumor, Protocol Specific
- capecitabine
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 30, 2018
Memory Impairment Trial in Dallas (Lamotrigine, Placebo)
Completed
- Memory Impairment
- Lamotrigine
- Placebo
-
Dallas, TexasParkland Health and Hospital System (Asthma, Allergy, & Arthriti
Jul 27, 2018
MDD Trial in Worldwide (ALKS 5461)
Completed
- Major Depressive Disorder
- ALKS 5461
-
Birmingham, Alabama
- +157 more
Nov 21, 2018